赵永晓, 王艳丽, 苏江华, 王哲, 刘娜. ≥45岁非酒精性脂肪肝病患者合并2型糖尿病的影响因素研究[J]. 实用预防医学, 2024, 31(5): 604-607.
ZHAO Yongxiao, WANG Yanli, SU Jianghua, WANG Zhe, LIU Na. Factors influencing nonalcoholic fatty liver disease patients aged 45 years and above and complicated with type 2 diabetes mellitus. , 2024, 31(5): 604-607.
[1] Powell EE, Wong VW, Rinella M. Non-alcoholic fatty liver disease[J]. Lancet, 2021,397(10290):2212-2224. [2] 朱蕗颖, 李雨晨, 邓利华, 等. 非酒精性脂肪性肝病相关肝外疾病的研究进展[J]. 临床肝胆病杂志, 2021,37(9):2215-2219. [3] Pouwels S,Sakran N,Graham Y,et al. Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss[J]. BMC Endocr Disord, 2022,22(1):63. [4] Tilg H,Adolph TE,Dudek M,et al. Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity[J]. Nat Meta, 2021,3(12):1596-1607. [5] Cloete L. Diabetes mellitus: an overview of the types, symptoms, complications and management[J]. Nurs Stand, 2022,37(1):61-66. [6] 张红杰, 王倩倩, 刘海韵, 等. 烟台市成人高血压、糖尿病患病率及相关因素分析[J]. 实用预防医学, 2022,29(2):141-144. [7] 中华医学会肝病学分会脂肪肝和酒精性肝病学组. 非酒精性脂肪性肝病诊疗指南(2010年修订版)[J]. 胃肠病学和肝病学杂志, 2010,19(6):483-487. [8] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2017年版)[J]. 中国实用内科杂志, 2018,38(4):292-344. [9] 陆佳萍, 叶晓梅, 韩辰宇, 等. 2型糖尿病合并非酒精性脂肪肝的危险因素及其与中国人内脏脂肪指数的相关性研究[J]. 中国实用内科杂志, 2022,42(11):925-929. [10] Ong J, Alswat K, Hamid S, et al. Nonalcoholic fatty liver disease in Asia, Africa, and Middle East region[J]. Clin Liver Dis, 2023,27(2):287-299. [11] 张金华, 龙辉, 刘群, 等. 非酒精性脂肪肝患者发生2型糖尿病危险因素分析[J]. 临床肝胆病杂志, 2009,25(2):129-130. [12] Mitrovic B,Gluvic ZM,Obradovic M,et al. Non-alcoholic fatty liver disease, metabolic syndrome, and type 2 diabetes mellitus: where do we stand today?[J]. Arch Med Sci, 2023,19(4):884-894. [13] Wiafe YA, Afihene MY, Anto EO, et al. Non-alcoholic fatty liver disease and liver fibrosis in persons with type 2 diabetes mellitus in Ghana: a study of prevalence, severity, and contributing factors using transient elastography[J]. J Clin Med, 2023,12(11):124-125. [14] 汪思亮, 田文君, 陆玮婷, 等. 非酒精性脂肪肝患者合并高血压的相关危险因素分析[J]. 现代医学, 2022,50(7):806-810. [15] 钱巧慧, 方琦, 郭建, 等. 非酒精性脂肪肝患者胰岛素抵抗程度与甲状腺结节的相关性研究[J]. 实用预防医学, 2018,25(6):717-719. [16] 滕斌, 诸瑞月, 孟德清, 等. 社区2型糖尿病合并隐匿性高血压患者临床特征及影响因素分析[J]. 中国医药导刊, 2023,25(2):199-204. [17] Salavatizadeh M, Soltanieh S, Ataei KA, et al. Association between dietary glycemic index and non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus[J]. Front Endocrinol (Lausanne), 2023,14:122-123. [18] Frankowski R, Kobierecki M, Wittczak A, et al. Type 2 diabetes mellitus, non-alcoholic fatty liver disease, and metabolic repercussions: the vicious cycle and its interplay with inflammation[J]. Int J Mol Sci, 2023,24(11):124-126. [19] 孟佩盈, 张小英, 袁洪波, 等. T2DM并发NAFLD患者的血清内脂素、Nesfatin-1及胰岛素抵抗变化及其意义[J]. 实用预防医学, 2020,27(6):745-747. [20] 罗艳霞. 中老年居民非酒精性脂肪肝与冠心病和糖尿病患病现状及影响因素[J]. 中国卫生工程学, 2019,18(4):550-552. [21] 中华医学会内分泌学分会, 中华医学会糖尿病学分会. 中国成人2型糖尿病合并非酒精性脂肪性肝病管理专家共识[J]. 中华内分泌代谢杂志, 2021,37(7):589-598. [22] 赵倩, 张锦娟, 鬲洋院, 等. 健康素养、授权能力对初诊2型糖尿病患者自我管理能力的影响研究[J]. 实用预防医学, 2023,30(3):305-309. [23] Bulur A, Sivritepe R. The Association between non-alcoholic fatty liver disease and dynapenia in men diagnosed with type 2 diabetes mellitus[J]. Healthcare (Basel), 2023,11(2):111-114. [24] Petunina NA, Telnova ME, Goncharova EV, et al. Non-alcoholic fatty liver disease and type 2 diabetes mellitus: general approaches to the choice of therapy[J]. Ter Arkh, 2022,94(10):1155-1162.